发病机制
炎症性肠病
炎症性肠病
基因
疾病
免疫学
生物
计算生物学
遗传学
医学
生物信息学
病理
作者
Hiutung Chu,Arya Khosravi,Indah P. Kusumawardhani,Alice H. K. Kwon,A.C. Vasconcelos,Larissa D. Cunha,A. Mayer,Yue Shen,Wei‐Li Wu,Amal Kambal,Stephan R. Targan,Ramnik J. Xavier,Peter B. Ernst,Douglas R. Green,Dermot McGovern,Herbert W. Virgin,Sarkis K. Mazmanian
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2016-05-06
卷期号:352 (6289): 1116-1120
被引量:595
标识
DOI:10.1126/science.aad9948
摘要
Genes and microbes converge in colitis Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
科研通智能强力驱动
Strongly Powered by AbleSci AI